Novavax, Inc. NVAX
9.94 USD -0.26 (-2.60%)
Nov 11, 2026, 3:09 PM EST
9.91 Day range 10.36
6.20 52-week range 13.39
- YTD
- +47.84%
- 1 year
- +33.53%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.12B | 682.16M | 983.71M | 1.98B | 1.15B | |
| 1.05B | 479.42M | 639.94M | 1.08B | 1.15B | |
| 452.80M | -248.93M | -566.51M | -644.74M | -1.69B | |
| 440.30M | -187.50M | -545.06M | -657.94M | -1.74B | |
| 2.72 | -1.23 | -5.41 | -8.42 | -23.44 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 251.51M | 540.86M | 578.93M | 1.35B | 1.53B | |
| 1.18B | 1.56B | 1.80B | 2.26B | 2.58B | |
| 1.30B | 2.18B | 2.51B | 2.89B | 2.93B | |
| 248.81M | 230.42M | 229.08M | 549.78M | 453.99M | |
| -127.75M | -623.84M | -716.93M | -634.08M | -351.67M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -244.63M | -87.26M | -713.97M | -415.94M | 322.95M | |
| -78.27M | -204.04M | -58.81M | -92.98M | 100.15M | |
| 27.74M | 260.58M | 4.47M | 324.99M | 461.71M | |
| -6.39M | -14.64M | -58.81M | -92.98M | -57.49M | |
| -289.24M | -38.52M | -765.03M | -179.41M | 879.52M |